Dow Jones

40,427.41

0.35%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
UK
LSE
Celadon Pharmaceuticals Plc (CEL)
Celadon Pharmaceuticals Plc (CEL) News

CEL Celadon Pharmaceuticals Plc

61.00

1.50 (2.52%)

22 Jul 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Celadon Pharmaceuticals Plc	LSE:CEL	London	Ordinary Share	GB00BDQYGP38	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	1.50	2.52%	61.00	57.00	65.00	61.00	59.50	59.50	12,246	14:00:11

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Investment Advice	149k	-7.14M	-0.1082	-5.64	39.26M

Director Shareholding

06/06/2005 5:59pm

UK Regulatory

RNS Number:2083N
Celsis International PLC
06 June 2005



                            Celsis International plc


                                 Share Options


6 June 2005: Celsis International plc today announces that following the
achievement of   the performance criteria set in the executive directors share
option plan dated 7 July 2004 (the "Scheme"), Jay LeCoque, Chief Executive, and
Christian Madrolle, Finance Director, have respectively become entitled to
options over 400,000 and 266,667 Ordinary Shares in the Company at a price of
32.75p per share.  Subject to the achievement of performance criteria,
additional options over respectively 800,000 and 533,333 Ordinary Shares have
been awarded under the Scheme to Jay LeCoque and Christian Madrolle at a price
of 32.75 p per share.


Enquiries:

Celsis International plc                                      Tel: 01638 600 151
Christian Madrolle, Finance Director & Company Secretary




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSUNVNRVARNRAR